Today, President Donald J. Trump announced the 17th agreement with a major pharmaceutical manufacturer, Regeneron, to lower prescription drug prices that Americans pay for some of the world’s most ...
TrumpRx has signed deals with 86% of the branded drug market. But are prices actually falling for most Americans? A doctor ...
President Donald Trump’s work to lower prescription drug costs for patients will undoubtedly be one of his most significant ...
Of the 17 companies that were implored by the White House last July to apply Most Favored Nation pricing to their drugs, ...
The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, ...
Regeneron is the latest pharmaceutical manufacturer to make a deal with the administration to offer some of their drugs at ...
The renewed debate over Most Favored Nation (MFN) drug pricing in the United States reflects a legitimate frustration: ...
Americans pay 278% more for same medications going to people in other countries. Executive Order ending this must be codified ...
Regeneron will be the final of 17 large pharmaceutical companies to sign such a drug pricing agreement with the Trump ...
The US pays higher drug prices than do peer nations, thereby financing a disproportionate share of global pharmaceutical research and development. President Donald Trump has announced himself willing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results